AzurRx BioPharma Announces Notice of Allowance of U.S. and Japan Patents Covering a MTAN Inhibitor for Treating H. Pylori Infections, the Primary Cause of Stomach Ulcers June 7, 2019 - NASDAQ Companies 0 » View More News for June 07, 2019